Premier Biomedical Financials

$24.3 K

Revenue Q3, 2017

$2.9 M

Mkt cap, 31-Oct-2017
Gross profit (Q3, 2017)13.2 K
Gross profit margin (Q3, 2017), %54%
Net income (Q3, 2017)3.7 M
Closing share price, 31-Oct-20170
Cash, 30-Sep-2017102.5 K

Market Value

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

R&D expense

217.4 k196.2 k234.1 k113.9 k

General and administrative expense

3 m223.4 k133.3 k191.4 k

Operating expense total

3.2 m419.6 k367.4 k305.2 k

Interest expense

400.4 k41.6 k198.9 k817.4 k

Net Income

(4.9 m)(1.4 m)(2.6 m)(1.8 m)

    Quarterly

    USDQ1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q3, 2017

    Revenue

    24.3 k

    Cost of goods sold

    11.1 k

    Gross profit

    13.2 k

    Gross profit Margin, %

    54%

    R&D expense

    2.7 k52.2 k56.9 k59.7 k10.1 k49.5 k46.1 k184.3 k

    General and administrative expense

    47.8 k40.3 k25.5 k44.8 k49.5 k42 k36.6 k37 k

    Operating expense total

    50.6 k92.5 k82.4 k104.5 k59.6 k91.5 k82.6 k243.6 k

    Interest expense

    29.5 k49.6 k48.5 k217.1 k202.4 k284 k37.1 k

    Net Income

    (307.3 k)(209.8 k)(936.6 k)(188.8 k)(415.1 k)(722.1 k)(435.1 k)3.7 m

      Balance Sheet

      Annual

      USDFY, 2013FY, 2014FY, 2015FY, 2016

      Cash

      15.8 k102.6 k35.4 k22.4 k

      Accounts Receivable

      171.5 m

      Current Assets

      21.8 k115.5 k66.5 k33.9 k

      PP&E

      3.7 k5.1 k3.6 k5.1 k

      Total Assets

      25.5 k120.6 k70.2 k39 k

      Accounts Payable

      122.3 k147.5 k188.3 k220.7 k

      Current Liabilities

      274.5 k188.4 k346.5 k699.7 k

      Total Liabilities

      699.7 k

      Additional Paid-in Capital

      6.5 m8.1 m10.5 m11.9 m

      Retained Earnings

      (8.2 m)(10.8 m)(12.6 m)

      Total Equity

      (249 k)(67.8 k)(276.3 k)(660.7 k)

      Financial Leverage

      -0.1 x-1.8 x-0.3 x-0.1 x

        Quarterly

        USDQ1, 2014Q2, 2014Q3, 2017

        Cash

        113.6 k199.4 k102.5 k

        Accounts Receivable

        834

        Inventories

        108 k

        Current Assets

        119.1 k231.7 k218.8 k

        PP&E

        3.5 k3.2 k5.9 k

        Total Assets

        122.6 k234.9 k224.7 k

        Accounts Payable

        17.8 k42.8 k350.1 k

        Current Liabilities

        20.8 k60 k2.9 m

        Total Liabilities

        2.9 m

        Additional Paid-in Capital

        7.1 m7.5 m12.8 m

        Retained Earnings

        (15.4 m)

        Total Equity

        101.8 k174.9 k(2.7 m)

        Financial Leverage

        1.2 x1.3 x-0.1 x

          Cash Flow

          Annual

          USDFY, 2013FY, 2014FY, 2015FY, 2016

          Net Income

          (4.9 m)(1.4 m)(2.6 m)(1.8 m)

          Depreciation and Amortization

          7679541.5 k2.1 k

          Accounts Payable

          33.7 k25.2 k40.8 k32.5 k

          Cash From Operating Activities

          (428.2 k)(639.1 k)(462.2 k)(483.6 k)

          Purchases of PP&E

          (1.4 k)(2.4 k)(3.5 k)

          Cash From Investing Activities

          (1.4 k)(2.4 k)(3.5 k)

          Cash From Financing Activities

          405.1 k728.3 k395 k474.2 k

          Interest Paid

          20.8 k32.6 k13.5 k

            Quarterly

            USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

            Net Income

            (307.3 k)(209.8 k)(936.6 k)(188.8 k)(415.1 k)(722.1 k)(435.1 k)

            Depreciation and Amortization

            233466

            Accounts Payable

            (104.6 k)(79.6 k)34.6 k209.5 k237.9 k299.4 k83.4 k143.7 k210.1 k

            Cash From Operating Activities

            (304.5 k)(418.6 k)

            Cash From Financing Activities

            402.3 k602.3 k

            Interest Paid

            32.6 k32.6 k

              Ratios

              Y, 2017

              Financial Leverage

              -0.1 x